Variant report
Variant | esv3352849 |
---|---|
Chromosome Location | chr6:65658931-65662129 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150573592 | chr6:65659007-65659008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542052800 | chr6:65659050-65659051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183567931 | chr6:65659058-65659059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562333872 | chr6:65659071-65659072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531213994 | chr6:65659093-65659094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551260937 | chr6:65659121-65659122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571182417 | chr6:65659143-65659144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532097619 | chr6:65659196-65659197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186765257 | chr6:65659238-65659239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11758096 | chr6:65659244-65659245 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs9294632 | chr6:65659275-65659276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191572146 | chr6:65659318-65659319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554447176 | chr6:65659368-65659369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114585421 | chr6:65659378-65659379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576959236 | chr6:65659381-65659382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72873092 | chr6:65659435-65659436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376618986 | chr6:65659468-65659469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556641737 | chr6:65659470-65659471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556811358 | chr6:65659472-65659473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112270154 | chr6:65659498-65659499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545780644 | chr6:65659500-65659501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182872246 | chr6:65659582-65659583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573233441 | chr6:65659592-65659593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542341362 | chr6:65659617-65659618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562055981 | chr6:65659627-65659628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9453120 | chr6:65659677-65659678 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs553136979 | chr6:65659709-65659710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188338868 | chr6:65659747-65659748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564729871 | chr6:65659786-65659787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9453121 | chr6:65659806-65659807 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs551883067 | chr6:65659871-65659872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559329352 | chr6:65659872-65659873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528160762 | chr6:65659873-65659874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs386702092 | chr6:65659898-65659899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9445445 | chr6:65659899-65659900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536807249 | chr6:65659900-65659901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550398932 | chr6:65659905-65659906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116584536 | chr6:65659933-65659934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539374644 | chr6:65659971-65659972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114153140 | chr6:65659975-65659976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs147348917 | chr6:65660011-65660012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs535502006 | chr6:65660027-65660028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139421320 | chr6:65660046-65660047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28484766 | chr6:65660110-65660111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147945259 | chr6:65660121-65660122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564717668 | chr6:65660132-65660133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73767195 | chr6:65660146-65660147 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs540961681 | chr6:65660163-65660164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560629431 | chr6:65660184-65660185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528039723 | chr6:65660206-65660207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65658800-65659400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:65659000-65659400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:65659000-65659600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr6:65659000-65659600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:65659400-65661000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:65661000-65661400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |